Tumor hypoxia seriously impairs the therapeutic outcomes of type II photodynamic therapy
(PDT), which is highly dependent upon tissue oxygen concentration. Herein, a facile strategy …

Photodynamic therapy (PDT) has shown great potential for tumor treatment with merits of
non‐invasiveness, high selectivity, and minimal side effects. However, conventional type II …

Designing mitochondria-targeting phototheranostic agents (PTAs), which can
simultaneously possess exceptional and balanced type-I photodynamic therapy (PDT) and …

Photodynamic therapy (PDT) has long been recognized to be a promising approach for
cancer treatment. However, the high oxygen dependency of conventional PDT dramatically …

In the current work, we synthesized an A–D–A smallmolecule photosensitizer, denoted as
DPTTIC, and a dual PEG-functionalized pillararene, denoted as WP5-8C-2PEG, and used …

In recent years, two-photon photodynamic therapy (TP-PDT) has received extensive
attention in cancer treatment owing to its unique advantages of deep tissue penetration and …

Simultaneous photothermal therapy (PTT) and photodynamic therapy (PDT) is beneficial for
enhanced cancer therapy due to the synergistic effect. Conventional materials developed for …

As a common feature in a majority of malignant tumors, hypoxia has become the Achilles'
heel of photodynamic therapy (PDT). The development of type‐I photosensitizers that show …

Photodynamic therapy (PDT) with an oxygen-dependent character is a noninvasive
therapeutic method for cancer treatment. However, its clinical therapeutic effect is greatly …

Photosensitizers play a critical role in photodynamic therapy (PDT). Multifunctional organic
nanoparticles (NPs) that possess bright fluorescence in aggregates, high singlet oxygen …